Grant: Master's Award: Canada Graduate Scholarships
University of Ottawa
$17,500.00
Investigating the Role of Platelet Polyphosphates in Heart Valve Calcification
FY 2013-14
Summary
Calcific aortic stenosis (CAS) is a recurring degenerative disease in which the opening of the aortic valve calcifies and becomes partially obstructed. This narrowed opening requires that heart muscles work harder to compensate for the reduced blood flow. This harder workload results in ventricular wall thickening, and increased risks of angina, syncope, arrhythmia, congestive heart failure or mortality. CAS may be congenital (in patients born with abnormalities), but it often develops later in life. The standard surgical treatment for CAS is aortic valve replacement. As CAS diagnosis is escalating in industrialized countries, the number of aortic valve replacement surgeries is expected to increase.
The underlying chemical principles of heart valvular tissue calcification are highly debated due to the amount of possible variables in this biological process. Aortic valve stenosis has been proposed to be similar to the molecular mechanisms of atherosclerosis (hardening of the arteries by deposition of plaque). Others contend that local cell death is involved in the progressive pathogenesis of CAS. Intracellular products extruded from those cells are proposed to play an important role by providing the necessary compounds for valve tissue calcification. It is possible that heart valve calcification may initiate within the valve tissue. The fundamental chemical mechanisms of the nucleation of heart valve calcifications have not been addressed.
Recent studies have investigated the role of polyphosphate (polyP) in mineralization of apatite (phosphate rich mineral found in many forms throughout the human body). Past research identified dense granules containing substantial amounts of polyP, which are secreted upon platelet activation. PolyP represents a potential store of phosphate for biomineralization, suggesting that platelets have the capacity to initiate apatite nucleation. We hypothesize that platelets may act as a mineralization initiator, possibly within heart valve cartilage.
Cells within the heart valve are affected by local shear stress changes caused by the turbulent flow that exists in the valves. This could lead to the disruption of the heart valve tissue surface, allowing for penetration of platelets into the tissue. Platelets that die within the heart valve tissue could result in polyP transformation to phosphate, initiating the calcification.
To validate this hypothesis, I propose an experimental plan that will bridge the gap in knowledge between recent breakthroughs in polyP chemistry and the possibility of heart valve calcification by platelets. The first part of this study will aim at confirming the presence of cellular polyP inclusions in human platelets (using Raman microscopy and staining with toluidine blue and DAPI). In the second part of the project, the production of phosphate ions from platelet polyP will be investigated, via natural and accelerated cell death. Finally, the turbulent conditions of cardiac valves will be mimicked, to determine if platelets can penetrate into the heart valve tissue. The tissues will be cross-sectioned, analyzed with Raman spectroscopy, and stained for polyP and phosphate.
Results from the proposed research are expected to provide a better understanding of this cardiovascular disease that affects a large segment of the population. This new understanding may enable new strategies for preventing heart valve calcifications that could have significant benefits for public health and the Canadian healthcare system.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
311832
Name
Lacroix Nicolas
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Role of Platelet Polyphosphates in Heart Valve Calcification
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Calcific Aortic Stenosis; Heart Valve Calcification; Human Platelets; Polyphosphates; Raman Microscopy
Abstract
Calcific aortic stenosis (CAS) is a recurring degenerative disease in which the opening of the aortic valve calcifies and becomes partially obstructed. This narrowed opening requires that heart muscles work harder to compensate for the reduced blood flow. This harder workload results in ventricular wall thickening, and increased risks of angina, syncope, arrhythmia, congestive heart failure or mortality. CAS may be congenital (in patients born with abnormalities), but it often develops later in life. The standard surgical treatment for CAS is aortic valve replacement. As CAS diagnosis is escalating in industrialized countries, the number of aortic valve replacement surgeries is expected to increase.
The underlying chemical principles of heart valvular tissue calcification are highly debated due to the amount of possible variables in this biological process. Aortic valve stenosis has been proposed to be similar to the molecular mechanisms of atherosclerosis (hardening of the arteries by deposition of plaque). Others contend that local cell death is involved in the progressive pathogenesis of CAS. Intracellular products extruded from those cells are proposed to play an important role by providing the necessary compounds for valve tissue calcification. It is possible that heart valve calcification may initiate within the valve tissue. The fundamental chemical mechanisms of the nucleation of heart valve calcifications have not been addressed.
Recent studies have investigated the role of polyphosphate (polyP) in mineralization of apatite (phosphate rich mineral found in many forms throughout the human body). Past research identified dense granules containing substantial amounts of polyP, which are secreted upon platelet activation. PolyP represents a potential store of phosphate for biomineralization, suggesting that platelets have the capacity to initiate apatite nucleation. We hypothesize that platelets may act as a mineralization initiator, possibly within heart valve cartilage.
Cells within the heart valve are affected by local shear stress changes caused by the turbulent flow that exists in the valves. This could lead to the disruption of the heart valve tissue surface, allowing for penetration of platelets into the tissue. Platelets that die within the heart valve tissue could result in polyP transformation to phosphate, initiating the calcification.
To validate this hypothesis, I propose an experimental plan that will bridge the gap in knowledge between recent breakthroughs in polyP chemistry and the possibility of heart valve calcification by platelets. The first part of this study will aim at confirming the presence of cellular polyP inclusions in human platelets (using Raman microscopy and staining with toluidine blue and DAPI). In the second part of the project, the production of phosphate ions from platelet polyP will be investigated, via natural and accelerated cell death. Finally, the turbulent conditions of cardiac valves will be mimicked, to determine if platelets can penetrate into the heart valve tissue. The tissues will be cross-sectioned, analyzed with Raman spectroscopy, and stained for polyP and phosphate.
Results from the proposed research are expected to provide a better understanding of this cardiovascular disease that affects a large segment of the population. This new understanding may enable new strategies for preventing heart valve calcifications that could have significant benefits for public health and the Canadian healthcare system.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Lacroix, Nicolas
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~